1. Home
  2. SMLR vs HYI Comparison

SMLR vs HYI Comparison

Compare SMLR & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMLR
  • HYI
  • Stock Information
  • Founded
  • SMLR 2007
  • HYI 2010
  • Country
  • SMLR United States
  • HYI United States
  • Employees
  • SMLR N/A
  • HYI N/A
  • Industry
  • SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HYI Investment Managers
  • Sector
  • SMLR Health Care
  • HYI Finance
  • Exchange
  • SMLR Nasdaq
  • HYI Nasdaq
  • Market Cap
  • SMLR 289.5M
  • HYI 279.2M
  • IPO Year
  • SMLR 2014
  • HYI N/A
  • Fundamental
  • Price
  • SMLR $60.71
  • HYI $12.09
  • Analyst Decision
  • SMLR
  • HYI
  • Analyst Count
  • SMLR 0
  • HYI 0
  • Target Price
  • SMLR N/A
  • HYI N/A
  • AVG Volume (30 Days)
  • SMLR 1.1M
  • HYI 50.6K
  • Earning Date
  • SMLR 11-04-2024
  • HYI 01-01-0001
  • Dividend Yield
  • SMLR N/A
  • HYI 9.59%
  • EPS Growth
  • SMLR N/A
  • HYI N/A
  • EPS
  • SMLR 2.04
  • HYI N/A
  • Revenue
  • SMLR $58,938,000.00
  • HYI N/A
  • Revenue This Year
  • SMLR N/A
  • HYI N/A
  • Revenue Next Year
  • SMLR N/A
  • HYI N/A
  • P/E Ratio
  • SMLR $27.98
  • HYI N/A
  • Revenue Growth
  • SMLR N/A
  • HYI N/A
  • 52 Week Low
  • SMLR $20.88
  • HYI $10.99
  • 52 Week High
  • SMLR $79.45
  • HYI $12.24
  • Technical
  • Relative Strength Index (RSI)
  • SMLR 62.87
  • HYI 48.56
  • Support Level
  • SMLR $52.00
  • HYI $11.87
  • Resistance Level
  • SMLR $63.29
  • HYI $12.14
  • Average True Range (ATR)
  • SMLR 8.79
  • HYI 0.15
  • MACD
  • SMLR 0.29
  • HYI 0.00
  • Stochastic Oscillator
  • SMLR 48.35
  • HYI 52.38

About SMLR Semler Scientific Inc.

Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.

About HYI Western Asset High Yield Defined Opportunity Fund Inc.

Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. It invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.

Share on Social Networks: